| (USD) | Jun 2026 | Y/Y change |
|---|---|---|
| Revenue | 190.70M | — |
| Operating expense | — | — |
| Net income | -43.20M | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, MYGN returned -49.3% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | -50.4% |
| 1 year | -49.3% |
| 5 years | -91.5% |
| 10 years | -85.0% |
| All-time high | $60.00 (Oct 2000) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what $1,000 in MYGN would be worth today ›No. Myriad Genetics, Inc. has not paid a dividend in the past 12 months.
Myriad Genetics, Inc. stock trades on NASDAQ under the ticker symbol MYGN.
Myriad Genetics, Inc. is part of the Healthcare sector.
Myriad Genetics, Inc. has a market cap of 291.73M USD, based on the latest quote.
